Benzinga | Apr 27, 2021 11:49AM EDT

Monness, Crespi, Hardt Downgrades Proofpoint to Neutral, Raises Price Target to $176

Monness, Crespi, Hardt analyst Andrew Nowinski downgrades Proofpoint (NASDAQ:PFPT) from Buy to Neutral and raises the price target from $160 to $176.